Health status and pharmaceutical programs: from cost minimization to cost-utility analysis.
D003362:Cost-Benefit Analysis / Q000379:methods*; D004358:Drug Therapy / Q000191:economics*; D006305:Health Status Indicators; D006801:Humans; D010043:Outcome and Process Assessment, Health Care / Q000379:methods*; D014481:United States